StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Sutent (sunitinib) [legacy through FY23] by Quarter

Sutent (sunitinib) [legacy through FY23] ($M) ($M)

QuarterlyAnnual

Pfizer Sutent (sunitinib) [legacy through FY23]: $44M in Q4 2023, down 26.7% from a year earlier. No newer figure appears in the documents we track.

Latest, Q4 2023
44
Period ended Dec 31, 2023
Change on a year earlier
-26.7%
60 in Q4 2022
History
24 quarters
Since Q1 2018
Sources
19
Documents cited below

Where the Q4 2023 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: Form 10-K (filed 2024-02-22) ↗

Reported in Form 10-K Segment Note.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSutent (sunitinib) [legacy through FY23] ($M) ($M)Year on yearSource
Q4 2023Dec 31, 202344-26.7%Form 10-K (filed 2024-02-22) ↗
Q3 2023Oct 1, 202342-44.0%Form 10-Q (filed 2023-11-08) ↗
Q2 2023Jul 2, 202345-53.6%Form 10-Q (filed 2023-08-09) ↗
Q1 2023Apr 2, 202350-56.1%Form 10-Q (filed 2023-05-10) ↗
Q4 2022Dec 31, 202260-55.9%Form 10-K (filed 2024-02-22) ↗
Q3 2022Oct 2, 202275-47.2%Form 10-Q (filed 2023-11-08) ↗
Q2 2022Jul 3, 202297-50.0%Form 10-Q (filed 2023-08-09) ↗
Q1 2022Apr 3, 2022114-43.0%Form 10-Q (filed 2023-05-10) ↗
Q4 2021Dec 31, 2021136-33.0%Form 10-K (filed 2024-02-22) ↗
Q3 2021Oct 3, 2021142-29.7%Form 10-Q (filed 2022-11-09) ↗
Q2 2021Jul 4, 2021194-7.2%Form 10-Q (filed 2022-08-10) ↗
Q1 2021Apr 4, 2021200-2.4%Form 10-Q (filed 2022-05-11) ↗
Q4 2020Dec 31, 2020203-12.5%Form 10-K (filed 2023-02-23) ↗
Q3 2020Sep 27, 2020202-9.8%Form 10-Q (filed 2021-11-12) ↗
Q2 2020Jun 28, 2020209-15.7%Form 10-Q (filed 2021-08-12) ↗
Q1 2020Mar 29, 2020205-11.6%Form 10-Q (filed 2021-05-13) ↗

Cite this data

StockData. (2026). Pfizer Sutent (sunitinib) [legacy through FY23] ($M), quarterly Q1 2018–Q4 2023 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/sutent-leg

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.